ResApp Fundamentals & General Discussion, page-120

Couldn't agree more @Quiltman. Thanks for the post.
I wonder whether it is worth setting up a thread analysing RAP purely from the perspective of medium to long term investors.

IMO this perspective gets completely overwhelmed by the short term holders and traders.

I will leave that to the more experienced HC posters to decide whether its worth setting one up...?
(if there is not one already)

What is important to me as a long term investor is:

- Continued enhancement of the RAP technology (algorithms, data security, scalability and user interface design etc.)
- Deep engagement with current and potential end users (and partners) of the technology
(ensuring RAP tech. can be seamlessly embedded into the end user workflow requirements. This is ultimately where the game is won or lost IMO)
- Regulatory engagement and approval pipeline
- Sales and distribution pipeline
- Sustainable revenue generation (selecting the correct business model, instead of chasing the short term sugar hit)
- Internal system and process integrity
- Overarching corporate governance (including a stringent no d***head policy)
- External communication integrity

If what you say is correct @Quiltman then radio silence is bliss.
Integrity is everything moving forward, unfortunately this will sometimes not be in alignment with the short term holders who are in this to make a quick buck.

If it takes another 6 months to land "the right" EU deal as opposed to the first thing that falls in our lap, then so be it IMO.
Choosing the wrong EU partner first up, could jeopardise the entire expansion.
Get it right first, then go like hell.

COVID-19 will live long in the memories of the future masters of the universe and telehealth / remote respiratory disease diagnosis aint going anywhere...

I note that this is all IMO, but truth be told I actually have NFI.
I will leave it to TK, his team and the board to get the job done.

Cheers